Medicare Enrolled
Dr. Ronald Ford, MD
Urology Physician · Amarillo, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ford from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ford?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ford
Dr. Ronald Ford is an urology physician in Amarillo, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ford performed 13,272 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Ford received a total of $5,273 from 34 pharmaceutical and/or device companies across 190 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ford is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 7% volume in TX
$5,273 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗13,272
Medicare services
Top 7% in TX for urology physician
Not available
Unique patients (not deduplicated)
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
9,102 | $0 | $2 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
1,013 | $3 | $21 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
644 | $59 | $175 |
| PSA test (prostate cancer screening) | 386 | $18 | $70 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
347 | $87 | $259 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
296 | $8 | $50 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
195 | $56 | $591 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
177 | $18 | $70 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
159 | $21 | $66 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
83 | $5 | $20 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
80 | $192 | $650 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 78 | $135 | $1,000 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
69 | $24 | $275 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
69 | $110 | $397 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
67 | $74 | $375 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
49 | $89 | $535 |
| Prostate needle biopsy pathology exam Laboratory examination of prostate tissue samples obtained via needle biopsy. The pathologist inspects the tissue both visually and under a microscope to identify any abnormalities. |
45 | $140 | $1,075 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
42 | $76 | $276 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
41 | $37 | $95 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
35 | $321 | $1,110 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
32 | $197 | $740 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
32 | $108 | $350 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
31 | $109 | $590 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
30 | $3 | $200 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
29 | $75 | $259 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
27 | $41 | $103 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
26 | $25 | $400 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
18 | $103 | $378 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
16 | $18 | $119 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
15 | $45 | $250 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
15 | $23 | $75 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
13 | $564 | $2,000 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
11 | $25 | $88 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.6% high complexity
73.7% medium
25.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,273
Total received (2018-2024)
Avg $753/year across 7 years
Top 37% in TX for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
190
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$258
2023
$456
2022
$736
2021
$712
2020
$1,504
2019
$935
2018
$671
Payments by company (2024)
Sumitomo Pharma America, Inc.
$57
PFIZER INC.
$40
Janssen Biotech, Inc.
$37
Astellas Pharma US Inc
$35
Novartis Pharmaceuticals Corporation
$30
Dendreon Pharmaceuticals LLC
$21
ABBVIE INC.
$21
Blue Earth Diagnostics Limited
$17
Top 3 companies account for 51.9% of 2024 payments
All-time payments by company (2018-2024) ›
CIPLA USA INC.
$1,302
Astellas Pharma US Inc
$1,192
ABBVIE INC.
$369
Medtronic USA, Inc.
$321
Dendreon Pharmaceuticals LLC
$305
Axonics, Inc.
$220
Janssen Biotech, Inc.
$180
Medtronic, Inc.
$137
Boston Scientific Corporation
$121
PFIZER INC.
$112
Merck Sharp & Dohme LLC
$109
AbbVie Inc.
$108
Amgen Inc.
$102
Janssen Scientific Affairs, LLC
$80
AstraZeneca Pharmaceuticals LP
$78
Sumitomo Pharma America, Inc.
$57
Blue Earth Diagnostics Limited
$45
TOLMAR Pharmaceuticals, Inc.
$42
AbbVie, Inc.
$39
Coloplast Corp
$35
UROVANT SCIENCES INC
$31
Novartis Pharmaceuticals Corporation
$30
Laborie Medical Technologies Corp.
$27
NeoTract Inc.
$26
BOSTON SCIENTIFIC CORPORATION
$25
Siemens Medical Solutions USA, Inc.
$25
Allergan, Inc.
$25
Allergan Inc.
$23
Olympus America Inc.
$21
Sun Pharmaceutical Industries Inc.
$19
Myriad Genetic Laboratories, Inc.
$19
Alnylam Pharmaceuticals Inc.
$16
SANOFI-AVENTIS U.S. LLC
$15
GENZYME CORPORATION
$15
Top 3 companies account for 54.3% of all-time payments
Associated products mentioned in payments ›
Androgel · Axonics · Axumin · BOTOX · BRACANALYSIS CDX · Bulkamid · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL THERAPIES · GENERAL THERAPIES · Halcyon · INTERSTIM · INTERSTIM ICON · JEVTANA · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LithoVue · Lupron · MYRBETRIQ · Myrbetriq · OXLUMO · PLUVICTO · POSLUMA · PROVENGE · Prolia · REZUM · Soltive · SpaceOAR VUE System - 10mL · SpeediCath · TOVIAZ · UroLift · VESICARE · XGEVA · XTANDI · YONSA · ZEMDRI (PLAZOMICIN)
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
10
County median income
$50,448
Nearest hospital to ZIP centroid (approximate)
NORTHWEST TEXAS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ford is a mixed practice specialist, with above-average Medicare volume (top 7% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ford experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Ford performed 9,102 contrast dye for imaging (iodine-based) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Ford receive payments from pharmaceutical companies?
Yes. Dr. Ford received a total of $5,273 from 34 companies across 190 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ford's costs compare to other urology physicians in Amarillo?
Dr. Ford's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ford) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Amarillo
Browse urology physicians in Amarillo ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
CIPLA USA INC. Payments to Doctors
See all physicians who received payments from CIPLA USA INC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology